General introduction 15 17. Ferretto S, Mattesi G, Migliore F, Susana A, De Lazzari M, Iliceto S, et al. Clinical predictors of pocket hematoma after cardiac device implantation and replacement. J Cardiovasc Med (Hagerstown). 2020;21(2):123-7. 18. Birnie DH, Healey JS, Wells GA, Ayala-Paredes F, Coutu B, Sumner GL, et al. Continued vs. interrupted direct oral anticoagulants at the time of device surgery, in patients with moderate to high risk of arterial thrombo-embolic events (BRUISE CONTROL-2). European Heart Journal. 2018;39(44):3973-9. 19. Ahsan SY, Saberwal B, Lambiase PD, Koo CY, Lee S, Gopalamurugan AB, et al. A simple infection-control protocol to reduce serious cardiac device infections. Europace. 2014;16(10):1482-9. 20. Brough CEP, Rao A, Haycox AR, Cowie MR, Wright DJ. Real-world costs of transvenous lead extraction: the challenge for reimbursement. Europace. 2019;21(2):290-7. 21. Blomström-Lundqvist C, Traykov V, Erba PA, Burri H, Nielsen JC, Bongiorni MG, et al. European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections-endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS), International Society for Cardiovascular Infectious Diseases (ISCVID) and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur J Cardiothorac Surg. 2020;57(1):e1-e31. 22. Wilkoff BL, Boriani G, Mittal S, Poole JE, Kennergren C, Corey GR, et al. Cost-Effectiveness of an Antibacterial Envelope for Cardiac Implantable Electronic Device Infection Prevention in the US Healthcare System From the WRAP-IT Trial. Circ Arrhythm Electrophysiol. 2020;13(10):e008503. 23. Birnie DH, Wang J, Alings M, Philippon F, Parkash R, Manlucu J, et al. Risk Factors for Infections Involving Cardiac Implanted Electronic Devices. Journal of the American College of Cardiology. 2019;74(23):2845-54. 24. Mittal S, Shaw RE, Michel K, Palekar R, Arshad A, Musat D, et al. Cardiac implantable electronic device infections: incidence, risk factors, and the effect of the AigisRx antibacterial envelope. Heart Rhythm. 2014;11(4):595-601. 25. Shariff N, Eby E, Adelstein E, Jain S, Shalaby A, Saba S, et al. Health and economic outcomes associated with use of an antimicrobial envelope as a standard of care for cardiac implantable electronic device implantation. Journal of cardiovascular electrophysiology. 2015;26(7):783-9. 26. Birnie DH, Wang J, Alings M, Philippon F, Parkash R, Manlucu J, et al. Risk Factors for Infections Involving Cardiac Implanted Electronic Devices. J Am Coll Cardiol. 2019;74(23):2845-54. 27. Correction. J Am Coll Cardiol. 2020;76(6):762. 28. Barry MJ, Edgman-Levitan S. Shared decision making—The pinnacle patient-centered care. 2012. 29. Arsad FS, Soffian SSS, Kamaruddin PSNM, Nordin NR, Baharudin MH, Baharudin UM, et al. The impact of eHealth applications in healthcare intervention: a systematic review. J Health Res. 2023;37. 30. Leclercq C, Witt H, Hindricks G, Katra RP, Albert D, Belliger A, et al. Wearables, telemedicine, and artificial intelligence in arrhythmias and heart failure: Proceedings of the European Society of Cardiology Cardiovascular Round Table EP Europace. 2022;24(9):1372-83. 31. Giacalone A, Marin L, Febbi M, Franchi T, Tovani-Palone MR. eHealth, telehealth, and telemedicine in the management of the COVID-19 pandemic and beyond: Lessons learned and future perspectives. World J Clin Cases. 2022;10(8):2363-8. 1
RkJQdWJsaXNoZXIy MTk4NDMw